MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism
PLoS ONE - United States
doi 10.1371/journal.pone.0152090
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 3, 2016
Authors
Publisher
Public Library of Science (PLoS)